104 related articles for article (PubMed ID: 478308)
41. Pharmacological approaches in the treatment of senile dementia.
Markstein R
Eur Neurol; 1989; 29 Suppl 3():33-41. PubMed ID: 2575520
[TBL] [Abstract][Full Text] [Related]
42. Vasodilators in senile dementia.
Maclay WP
Br Med J; 1979 Oct; 2(6194):866. PubMed ID: 509139
[No Abstract] [Full Text] [Related]
43. Electroencephalographic and clinical changes as correlated in geriatric patients treated three months with an ergot alkaloid preparation.
Matejcek M; Knor K; Piguet PV; Weil C
J Am Geriatr Soc; 1979 May; 27(5):198-202. PubMed ID: 372291
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic possibilities in patients with senile dementia.
Castleden CM
J R Coll Physicians Lond; 1984 Jan; 18(1):28-31. PubMed ID: 6323706
[No Abstract] [Full Text] [Related]
45. The evaluation of drugs in Alzheimer's disease.
Isaacs B
Age Ageing; 1979 Feb; 8(1):1-7. PubMed ID: 443105
[No Abstract] [Full Text] [Related]
46. Preliminary observations on naltrexone for treatment of Alzheimer's type dementia.
Tennant FS
J Am Geriatr Soc; 1987 Apr; 35(4):369-70. PubMed ID: 3559033
[No Abstract] [Full Text] [Related]
47. Lecithin in Alzheimer's disease.
Levy R
Lancet; 1982 Sep; 2(8299):671-2. PubMed ID: 6125806
[No Abstract] [Full Text] [Related]
48. Drug treatment of memory defects in the elderly.
Hollister LE
Psychosomatics; 1984 Dec; 25(12 Suppl):23-8. PubMed ID: 6514989
[No Abstract] [Full Text] [Related]
49. Cholinergic precursors in Alzheimer's disease.
Pomara N; Stanley M
Lancet; 1982 Nov; 2(8306):1049. PubMed ID: 6127534
[No Abstract] [Full Text] [Related]
50. Vasodilators in senile dementia.
Yesavage J
Br Med J; 1979 Nov; 2(6199):1223-4. PubMed ID: 519381
[No Abstract] [Full Text] [Related]
51. Clinical effects of choline in Alzheimer's disease.
Etienne P; Gauthier S; Johnson G; Collier B; Mendis T; Dastoor D; Cole M; Muller HF
Lancet; 1978 Mar; 1(8062):508-9. PubMed ID: 76060
[No Abstract] [Full Text] [Related]
52. Hydergine and reversibility of cyclosporin nephrotoxicity.
Kho TL; Kengen R; Leunissen KM; Teule J; van Hooff JP
Lancet; 1986 Aug; 2(8503):394-5. PubMed ID: 2874389
[No Abstract] [Full Text] [Related]
53. Co-dergocrine mesylate (Hydergine) and hypertensive emergencies.
Romero R; Felip A; Llibre JM; Bonet J; Caralps A
Nephron; 1989; 51(1):127-8. PubMed ID: 2915745
[No Abstract] [Full Text] [Related]
54. Senile dementia: combined pharmacologic and psychologic treatment.
Yesavage JA; Westphal J; Rush L
J Am Geriatr Soc; 1981 Apr; 29(4):164-71. PubMed ID: 7204812
[TBL] [Abstract][Full Text] [Related]
55. Drugs and dementia.
Judge TG
Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):81-2. PubMed ID: 973950
[No Abstract] [Full Text] [Related]
56. Clinical pharmacology of senile dementia.
Fisman M
Prog Neuropsychopharmacol; 1981; 5(5-6):447-57. PubMed ID: 6122228
[No Abstract] [Full Text] [Related]
57. Alzheimer disease.
Sunderland T
South Med J; 2005 Jun; 98(6):588-9. PubMed ID: 16004163
[No Abstract] [Full Text] [Related]
58. Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer's Disease and Related Dementias.
Rudolph KA
AJOB Neurosci; 2023; 14(2):136-138. PubMed ID: 37097843
[No Abstract] [Full Text] [Related]
59. Dementia--further progress.
Kendall MJ
J Clin Pharm Ther; 1987 Jun; 12(3):135-6. PubMed ID: 3611210
[No Abstract] [Full Text] [Related]
60. [Pharmacotherapy of dementia].
Pavlović DM; Pavlović AM; Totić S
Vojnosanit Pregl; 2010 May; 67(5):419-26. PubMed ID: 20499737
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
